dr. crinò on crizotinib in alk nsclc
Published 10 years ago • 326 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
0:44
dr. mark kris discusses crizotinib for patients with alk-positive lung cancer
-
1:05
dr. west discusses crizotinib in alk-nsclc trial results
-
1:11
dr. salgia on crizotinib and other tkis in alk-positive nsclc
-
1:09
dr. camidge on crizotinib as a ros1 inhibitor in nsclc
-
1:14
dr. rotow on first-line brigatinib versus crizotinib in alk nsclc
-
1:17
dr. christina baik on alectinib versus crizotinib in alk-positive lung cancer
-
8:47
dr uma dangi | brigatinib versus crizotinib in alk inhibitor naive advanced alk positive nsclc
-
0:42
dr. west discusses alk-nsclc crizotinib survival benefit
-
7:02
crizotinib for alk-rearranged nsclc
-
1:58
dr. shaw on crizotinib in alk-positive lung cancer
-
4:10
crizotinib resistance in alk nsclc
-
1:27
dr. ou on the use of crizotinib in patients with ros1-rearranged nsclc
-
1:42
dr. alice shaw compares crizotinib and chemotherapy in nsclc
-
4:38
patterns of progression on crizotinib for alk nsclc
-
1:45
dr. shaw on using crizotinib to treat lung cancer
-
1:52
dr. shaw on crizotinib versus chemotherapy in alk-positive nsclc
-
1:06
comparing alectinib versus crizotinib in alk nsclc
-
1:15
dr. li discusses the profile crizotinib clinical trials
-
1:34
dr. camidge on the alta study of brigatinib in nsclc